Lung Cancer Surgery Market is expected to reach the Value of USD 5,092.07 Million, with Growing CAGR of 5.5% by the end of 2029, Size, Share, Growth, Demand and Opportunity Outlook

Technology advancement are of immense importance in the surgery of lung cancer. The importance of technological advancement has now taken almost every aspect of our lives

| Source: Data Bridge Market Research Data Bridge Market Research

New York, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Data Bridge Market Research has just released its extensive report on the "Lung Cancer Surgery Market" which details the industry's past, present, and future in terms of products and marketing. This Lung Cancer Surgery report contains comprehensive data on market definition, classifications, applications, engagements, market drivers, and market restraints of this industry all of which is derived from Porter's Five Forces analysis. With the specific base year and the historic year, assessments and calculations are conducted in the report. This helps to know how the market is going to act in the forecast years by providing information about market definition, classifications, applications, and engagements. All the statistical data, which is computed with the most authentic tools such as SWOT analysis, is characterized with the help of graphs and charts for the best user experience and clear understanding.

The global lung cancer surgery market is expected to gain significant market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.5% in the forecast period of 2022 to 2029 and is expected to reach USD 5,092.07 million by 2029.

Download the Exclusive Sample Report in PDF Version @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-surgery-market

A wedge surgery is a procedure used to remove lung cancer along with a little amount of good tissue. Segmental resection refers to the removal of a bigger portion of the lung. A lobectomy is a procedure to remove one of the five lobes of the lung. Pneumonectomy is the surgical removal of the whole lung.

Depending on the kind, location and stage of their lung cancer as well as any other medical issues, certain people may be candidates for lung cancer surgery. This kind of surgery is used to treat lung cancer. It involves removing the tumour, some lung tissue around it and frequently some lymph nodes as well. When lung cancer is limited and not anticipated to have spread, surgery to remove the tumour is thought to be the best option. This includes carcinoid tumours and non-small cell lung cancer in its early stages.

Recent Development

In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

Some of the major players operating in the Lung Cancer Surgery market are

  • AngioDynamics
  • Ackermann
  • Scanlan International
  • KLS Martin Group
  • Wexler Surgical
  • Lepu Medical Technology(Beijing)Co.Ltd.
  • Intuitive Surgical
  • FusionKraft
  • Surgical Holdings
  • GerMedUSA
  • Medtronic
  • Accuray Incorporated
  • Teleflex Incorporated
  • KARL STORZ SE & Co. KG
  • TROKAMED GmbH
  • Richard Wolf GmbH
  • Sontec Instruments
  • asap endoscopic products GmbH
  • FUJIFILM Holdings America Corporation
  • Ambu A/S.
  • Johnson & Johnson Services
  • Olympus Corporatio

Checkout Full Research Report at https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-lung-cancer-surgery-market

Lung Cancer Surgery Key Benefits over Global Competitors:

  • The report provides a qualitative and quantitative analysis of the Lung Cancer Surgery Market trends, forecasts, and market size to determine new opportunities.
  • Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
  • Top impacting factors & major investment pockets are highlighted in the research.
  • The major countries in each region are analyzed and their revenue contribution is mentioned.
  • The market player positioning segment provides an understanding of the current position of the market players active in the Lung Cancer Surgery Market

Lung Cancer Surgery Market Scope:

By Product Type

  • Surgical Instruments
  • Monitoring & Visualizing System
  • Endosurgical Equipment
  • Robotic-Assisted Thoracic Surgery Systems

By Surgical Procedure

  • Thoracotomy
  • Minimally Invasive Surgery

By Patient Type

  • Male
  • Female

By End User

  • Hospitals
  • Ambulatory & Surgical Centers
  • Academic & Research Institutes
  • Specialty Cancer Care Center

By Distribution Channel

  • Direct Tender
  • Retail Sales
  • Online Sales

Opportunities

  • Rise of Minimally Invasive Techniques in Lung Cancer Surgery

Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.

Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the lung cancer surgery industry

Browse More about This Premium Research Report at https://www.databridgemarketresearch.com/reports/global-lung-cancer-surgerymarket

Key Market Drivers:

  • Increased Prevalence Of Lung Cancer Diseases

Lung cancer is the most common leading cause of death in men and women globally. The incidence and mortality from lung cancer increasing globally due to the commencement of the tobacco epidemic in various countries and populations in the developing world. Lung cancer, including trachea and bronchus cancer, is widely regarded as a threat to global health, causing a heavy burden on individuals and families. Lung cancer is a malignant tumor characterized by the uncontrolled growth of cell tissues in the lung. It is the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. According to the GLOBOCAN, Lung cancer is the most common malignancy diagnosed worldwide, with an age-standardized incidence rate of 22.5 per 100,000 person-years. Men have a higher chance of developing lung cancer than women. However, since the middle of the 1990s, male patient incidence rates have decreased in most developed countries, while female patient incidence rates have steadily grown.

  • Technological Advancement In The Field Of Healthcare

Technology advancement are of immense importance in the surgery of lung cancer The importance of technological advancement has now taken almost every aspect of our lives. However, the most significant benefits are due to technological advances in health care. By developing new methodologies for treatment, the health system's technology becomes more effective. Recent technological advances have saved millions of lives and increased the quality of life.

In the people of all ages lung cancer is a well-known and prevalent disorder. The cutting –edge technology helps in providing better options for screening the disease. Thus, introduction of technological advanced products for the treatment of lung cancer acts as a driver for the growth of the market

  • Increased Awareness Regarding The Benefits

The growing awareness programs of lung cancer by non-profit, private and public organization is leveraging to boost the market growth. These initiatives aim to reducing stigma and prejudice, prevent diseases and promoting research.

The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the lung cancer surgery market.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Lung Cancer Surgery Market Regulations
  6. Market Overview
  7. Global Lung Cancer Surgery Market, By Component
  8. Global Lung Cancer Surgery Market, By Gene Type
  9. Global Lung Cancer Surgery Market, By Gene Synthesis Type
  10. Global Lung Cancer Surgery Market, By Application
  11. Global Lung Cancer Surgery Market, By Method
  12. Global Lung Cancer Surgery Market, By End User
  13. Global Lung Cancer Surgery Market, By Distribution Channel
  14. Global Lung Cancer Surgery Market, By Region
  15. Global Lung Cancer Surgery Market: Company Landscape
  16. SWOT Analyses
  17. Company Profile
  18. Questionnaires
  19. Related Reports

Grab the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-lung-cancer-surgery-market

Frequently Asked Questions

  1. What is the Future Market Value for Lung Cancer Surgery Market?
  2. What is the Growth Rate of the Lung Cancer Surgery Market?
  3. What are the Major Companies Operating in the Lung Cancer Surgery Market?
  4. Which Countries Data is covered in the Lung Cancer Surgery Market?
  5. What are the Main Data Pointers Covered in Lung Cancer Surgery Market Report?

Browse Related Reports:

  • Europe Lung Cancer Surgery Market, By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems And Others),  Surgical Procedure (Thoracotomy And Minimally Invasive Surgery), Patient Type (Male And Female), End User (Hospitals, Ambulatory Surgical Centres, Academic & Research Laboratories, Speciality Cancer Care Centres And Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales and Others) - Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/europe-lung-cancer-surgery-market
  • Lung Cancer Therapeutics Market, By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastinal Tumours, Mesothelioma, Chest Wall Tumours), Molecule Type (Small Molecules and Biologics), Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors and Others), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy and Others), Therapy Type (Single Drug Therapy and Combination Therapy), End User (Hospitals, Homecare, Speciality Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others) https://www.databridgemarketresearch.com/reports/global-lung-cancer-therapeutics-market
  • North America Lung Cancer Therapeutics Market, By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastinal Tumours, Mesothelioma, Chest Wall Tumours), Molecule Type (Small Molecules and Biologics), Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multikinase Inhibitors and Others), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy and Others), Therapy Type (Single Drug Therapy and Combination Therapy), End User (Hospitals, Homecare, Speciality Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others), Country (U.S., Canada and Mexico) https://www.databridgemarketresearch.com/reports/north-america-lung-cancer-therapeutics-market
  • Non-Small Cell Lung Cancer Market, By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung Cancer, Pulmonary Neuroendocrine Tumours, Mediastina Tumours, Mesothelioma and Chest Wall Tumours), Molecule Type (Small Molecules and Biologics), Drug Class (Alkylating Agents, Antimetabolites, EGFR Inhibitors, Mitotic Inhibitors, Multi-kinase Inhibitors and Others), Treatment Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy and Others), Therapy Type (Single Drug Therapy and Combination Therapy), End User (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others), Country https://www.databridgemarketresearch.com/reports/global-non-small-cell-lung-cancer-market
  • Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market
  • North America Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) https://www.databridgemarketresearch.com/reports/north-america-lung-cancer-screening-software-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us: -

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: corporatesales@databridgemarketresearch.com


Mot-clé

Lung Cancer Surgery Market Lung Cancer Surgery Lung Cancer market size Lung Cancer market share Lung Cancer market trends

Hyperliens